47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.A - Production of dental devices, instruments, and products
32.50.B - Other production of medical devices, instruments, and products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
73.12.Z - Advertising through mass media
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0 | 0 | 0 |
EBITDA | 2,1 | 1,8 | 1,4 | -19,6 |
Short time liabilities | 6,8 | 8,2 | 6,1 | -26,3 |
Equity capital | 3,5 | 4,1 | 4,6 | 11,9 |
Operating profit (EBIT) | 1,2 | 0,7 | 0,7 | 3,4 |
Assets | 10,5 | 12,7 | 11 | -12,9 |
Net profit (loss) | 0 | 0 | 0 | 0 |
Cash | 0,6 | 2,2 | 1,3 | -41,8 |
Liabilities and provisions for liabilities | 7,1 | 8,5 | 6,4 | -24,8 |
Net income from sale | 30,5 | 36 | 37,2 | 3,5 |
Working assets | 7,3 | 8,8 | 7,9 | -10,5 |
Depreciation | 1 | 1,1 | 0,8 | -32,9 |
% | % | % | p.p. | |
Profitability of capital | 0 | 0 | 0 | 0 |
Equity capital to total assets | 32,9 | 32,6 | 41,8 | 9,2 |
Gross profit margin | 0 | 0 | 0 | 0 |
EBITDA Margin | 6,9 | 5 | 3,9 | -1,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 81 | 83 | 59 | -24 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane